Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells

被引:34
|
作者
Blume, Lawrence C. [1 ]
Eldeeb, Khalil [1 ]
Bass, Caroline E. [1 ]
Selley, Dana E. [2 ]
Howlett, Allyn C. [1 ]
机构
[1] Wake Forest Univ Hlth Sci, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
CB1; receptor; CRIP1a; cAMP; ERK1/2; G protein; Endocannabinoid; ADENYLATE-CYCLASE; TYROSINE KINASES; INVERSE AGONIST; BRAIN; TRANSDUCTION; PHARMACOLOGY; ASSOCIATION; ENDOCYTOSIS; INHIBITION; ACTIVATION;
D O I
10.1016/j.cellsig.2014.11.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CBI cannabinoid receptors (CB1R) are one of the most abundantly expressed G protein coupled receptors (GPCR) in the CNS and regulate diverse neuronal functions. The identification of GPCR interacting proteins has provided additional insight into the fine-tuning and regulation of numerous GPCRs. The cannabinoid receptor interacting protein 1a (CRIP1a) binds to the distal carboxy terminus of CB1R, and has been shown to alter CB1R-mediated neuronal function [1]. The mechanisms by which CRIP1a regulates CB1R activity have not yet been identified; therefore the focus of this investigation is to examine the cellular effects of CRIP1a on CB1R signaling using neuronal N18TG2 cells stably transfected with CRIP1a over-expressing and CRIP1a knockdown constructs. Modulation of endogenous CRIP1 a expression did not alter total levels of CB1R, ERK, or forskolin-activated adenylyl cyclase activity. When compared to WT cells, CRIP1a over-expression reduced basal phosphoERK levels, whereas depletion of CRIP1a augmented basal phosphoERK levels. Stimulation of phosphoERK by the CB1R agonists WIN55212-2, CP55940 or methanandamide was unaltered in CRIP1a over-expressing clones compared with WT. However, CRIP1 a knockdown clones exhibited enhanced ERIC phosphorylation efficacy in response to CP55940. In addition, CRIP1a knockdown clones displayed a leftward shift in CP55940-mediated inhibition of forskolin-stimulated cAMP accumulation. CB1R-mediated G(i3) and G(o) activation by CP99540 was attenuated by CRIP1a over-expression, but robustly enhanced in cells depleted of CRIP1a. Conversely, CP55940-mediated and G(i2) activation was significant enhanced in cells over-expressing CRIP1a, but not in cells deficient of CRIP1a. These studies suggest a mechanism by which endogenous levels of CRIP1a modulate CB1R-mediated signal transduction by facilitating a G(i/o) protein subtype preference for G(i1) and G(i2), accompanied by an overall suppression of G-protein-mediated signaling in neuronal cells. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:716 / 726
页数:11
相关论文
共 50 条
  • [21] Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43
    Maroto, Irene B.
    Moreno, Estefania
    Costas-Insua, Carlos
    Merino-Gracia, Javier
    Diez-Alarcia, Rebeca
    Alvaro-Blazquez, Alicia
    Canales, Angeles
    Canela, Enric I.
    Casado, Vicent
    Uriguen, Leyre
    Rodriguez-Crespo, Ignacio
    Guzman, Manuel
    NEUROPHARMACOLOGY, 2023, 240
  • [22] CB1 Cannabinoid Receptor Signaling and Biased Signaling
    Leo, Luciana M.
    Abood, Mary E.
    MOLECULES, 2021, 26 (17):
  • [23] Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
    Navarro-Dorado, Jorge
    Villalba, Nuria
    Prieto, Dolores
    Brera, Begona
    Martin-Moreno, Ana M.
    Tejerina, Teresa
    de Ceballos, Maria L.
    FRONTIERS IN NEUROSCIENCE, 2016, 10
  • [24] Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) ?Cis-On? Agonist
    Rodriguez-Soacha, Diego A.
    Steinmueller, Sophie A. M.
    Isbilir, Ali
    Fender, Julia
    Deventer, Marie H.
    Ramirez, Yesid A.
    Tutov, Anna
    Sotriffer, Christoph
    Stove, Christophe P.
    Lorenz, Kristina
    Lohse, Martin J.
    Hislop, James N.
    Decker, Michael
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (16): : 2410 - 2435
  • [25] Interference with the Cannabinoid Receptor CB1R Results in Miswiring of GnRH3 and AgRP1 Axons in Zebrafish Embryos
    Zuccarini, Giulia
    D'Atri, Ilaria
    Cottone, Erika
    Mackie, Ken
    Shainer, Inbal
    Gothilf, Yoav
    Provero, Paolo
    Bovolin, Patrizia
    Merlo, Giorgio Roberto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [26] Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
    Ryalls, Beth
    Patel, Monica
    Sparkes, Eric
    Banister, Samuel D.
    Finlay, David B.
    Glass, Michelle
    BIOCHEMICAL PHARMACOLOGY, 2024, 222
  • [27] Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist
    Polini, Beatrice
    Cervetto, Chiara
    Carpi, Sara
    Pelassa, Simone
    Gado, Francesca
    Ferrisi, Rebecca
    Bertini, Simone
    Nieri, Paola
    Marcoli, Manuela
    Manera, Clementina
    LIFE-BASEL, 2020, 10 (12): : 1 - 14
  • [28] A New Perspective of Cannabinoid 1 Receptor Antagonists: Approaches Toward Peripheral CB1R Blockers without Crossing the Blood-Brain Barrier
    Wu, Yen-Ku
    Yeh, Ching-Fang
    Ly, Tai Wei
    Hung, Ming-Shiu
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (12) : 1421 - 1429
  • [29] Type-1 Cannabinoid Receptor Signaling in Neuronal Development
    Gaffuri, Anne-Lise
    Ladarre, Delphine
    Lenkei, Zsolt
    PHARMACOLOGY, 2012, 90 (1-2) : 19 - 39
  • [30] The cannabinoid CB1 receptor is expressed in pancreatic δ-cells
    Tharp, William G.
    Lee, Yong-Ho
    Maple, Rhonda L.
    Pratley, Richard E.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (04) : 595 - 600